Global /United States /Healthcare /Biotechnology /ALBT

Avalon GloboCare Corp.

ALBT

• NASDAQ: ALBT • Delayed

0.3997USD -4.4%

As of 13 June 2026, Avalon GloboCare Corp. has a market cap of $3.33M USD, ranking #45847 globally and #5822 in the United States. It ranks #4060 in the Healthcare sector, and #795 in the Biotechnology industry.

Global Rank

45847

Country Rank

5822

Sector Rank

4060

Industry Rank

795

Key Stats

Market Cap

$3.33MUSD

Enterprise Value

$4.31MUSD

Revenue (TTM)

$392.68KUSD

EBITDA (TTM)

-$7.5MUSD

Net Income (TTM)

-$18.1MUSD

PS Ratio

8.9

PB Ratio

0.4

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

Meng Li open_in_new

Employees

Founded

2014

Website

avalon-globocare.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.4%	-4.1%	-20%	-50%	-81%	-67%	-90%	-99%	-100%

News

ALBT Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	ALBT Avalon Globocare Corp ISIN: US05344R3021 Shares Out.: Shares Outstanding: 12.048M¹ Shares Float: 11.181M² TV: TradingView: NASDAQ: ALBT SA: Stock Analysis: NASDAQ: ALBT YF: Yahoo Finance: ALBT GF: Google Finance: NASDAQ: ALBT NQ: NASDAQ: ALBT BA: Barron's: ALBT MS: Morningstar: XNAS: ALBT	0.3997 USD	TV: TradingView: NASDAQ: ALBT SA: Stock Analysis: NASDAQ: ALBT YF: Yahoo Finance: ALBT GF: Google Finance: NASDAQ: ALBT NQ: NASDAQ: ALBT BA: Barron's: ALBT MS: Morningstar: XNAS: ALBT

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Avalon GloboCare Corp.

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 5M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 5M%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 830K%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 790K%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 752K%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 545K%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 1M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 1M%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 1M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 1M%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 845K%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 772K%	-	Germany

chevron_leftBack